Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alberto Camerini
Observed names:
A CAMERINI,
A Camerini,
A. CAMERINI,
A. Camerini,
Camerini, Alberto
Institutions:
Ospedale Versilia,
Fondazione Toscana Gabriele Monasterio,
Azienda Ospedaliera Universitaria Pisana,
Azienda USL Toscana Nord Ovest
Observed institutions:
Ente Ospedaliero Ospedali Galliera,
Ospedale Versilia,
Fondazione Toscana Gabriele Monasterio,
Azienda Ospedaliera Universitaria Pisana,
Azienda USL Toscana Nord Ovest
OpenAlex ID:
A5059212668
[Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG].
2001
·
A Camerini
·
PubMed
·
47
Panoramic Coronary Angiography
1998
·
Giorgio Tommasini
, Alberto Camerini
, et al.
·
Journal of the American College of Cardiology
·
39
PDF
Predicting cardiac mortality after uncomplicated myocardial infarction by exercise radionucide ventriculography and exercise-induced ST segment elevation
1992
·
G. MAZZOTTA
, A. CAMERINI
, et al.
·
European Heart Journal
·
9
Predicting severe ischemic events after uncomplicated myocardial infarction by exercise testing and rest and exercise radionuclide ventriculography
1994
·
Gianfranco Mazzotta
, Alberto Camerini
, et al.
·
Journal of Nuclear Cardiology
·
8
A patient with COVID-19 presenting multiple thrombi in the left ventricle
2020
·
Paolo Rubartelli
, Aldo Toselli
, et al.
·
Acta cardiologica. Supplementum
·
7
EP02.04-001 Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-Positive NSCLC: ALNEO Phase II Trial (GOIRC-01-2020)
2022
·
A. Leonetti
, R. Minari
, et al.
·
Journal of Thoracic Oncology
·
3
[Recommendations for cardiovascular rehabilitation in diabetes mellitus].
2003
·
Alberto Camerini
, Carmine Chieffo
, et al.
·
PubMed
·
3
Prevention of Sudden Cardiac Death in Non-Competitive Athletes: ECG Screening by Telecardiology Is Useful and Cost-Effective
2023
·
Martina Molinari
, Tiziano Gabriele Costigliolo
, et al.
·
American Journal of Internal Medicine
·
2
PDF
Renal scintigraphic captopril test: comparison of scintigraphic and angiographic data and preliminary observations in chronic glomerulonephritis.
1988
·
Enza Fommei
, S Ghione
, et al.
·
CINECA IRIS Institutial research information system (University of Pisa)
·
2
MA02.05 Liquid Biopsy in BRAF V600E NSCLC Treated With Dabrafenib Plus Trametinib: Final Analysis of LiBRA Study (GOIRC-03-2020)
2025
·
A. Leonetti
, R. Minari
, et al.
·
Journal of Thoracic Oncology
·
1
[Data from the IN-HF Outcome registry].
2012
·
Gianfranco Misuraca
, Giuseppe Di Tano
, et al.
·
PubMed
·
1
Use of digitalis in the treatment of heart failure: data from the Italian Network on Congestive Heart Failure (IN-CHF).
2004
·
Alberto Camerini
, Raffaele Griffo
, et al.
·
PubMed
·
1
[Implementing cardiovascular prevention in the real world: presentation of an integrated hospital-field model].
2003
·
Raffaele Griffo
, Massimo Blondett
, et al.
·
PubMed
·
1
P1589 Use of digoxin in the treatment of heart failure: How? When? In which patients? Data from the Italian network on congestive heart failure (IN-CHF)
2003
·
A CAMERINI
·
European Heart Journal
·
1
[The prognostic stratification of the risk of sudden death and sustained ventricular tachycardia after an acute myocardial infarct: which patients should undergo programmed ventricular stimulation?].
1994
·
M Z Berisso
, D Molini
, et al.
·
PubMed
·
1
2799eP Treatment of dialysis patients with advanced non-small cell lung cancer with single agent oral metronomic vinorelbine
2026
·
A. Camerini
, M.A. Grosso
, et al.
·
Annals of Oncology
EP.11.20 Real World-Outcomes of Advanced Non-Squamous NSCLC Patients Treated With First-Line Chemo-Immunotherapy According to KRAS Status
2025
·
F. Perrone
, A. Leonetti
, et al.
·
Journal of Thoracic Oncology
P1.11.24 Real-World Evidence of Primary Resistance to First-Line Chemo-Immunotherapy in Advanced Lung Adenocarcinoma
2025
·
M. Peroni
, A. Leonetti
, et al.
·
Journal of Thoracic Oncology
P1.17.54 Long-Term Outcomes From Pembrolizumab in Patients With Advanced PD-L1 =50% NSCLC and Poor PS: A Transformer-Based AI Approach
2025
·
A. Cortellini
, E. Garbo
, et al.
·
Journal of Thoracic Oncology
1905P 15 years single center experience in the treatment of advanced non-small cell lung cancer with single agent oral metronomic vinorelbine in challenging clinical settings
2025
·
A. Camerini
, M.A. Grosso
, et al.
·
Annals of Oncology
Gliflozines in active cancer patients with heart failure: final results on safety and effectiveness in the observational TOSCA trial
2025
·
M L Canale
, I Fabiani
, et al.
·
European Heart Journal Supplements
PDF
Management of Immunotherapy in Cancer Patients With Atherosclerosis–related Acute Coronary Syndrome
2025
·
M Canale
, I Fabiani
, et al.
·
European Heart Journal Supplements
EP.12H.05 Phase II Study on Platinum-Pemetrexed and Lorlatinib Combination in ALK-Positive NSCLC Extracranially Progressing on Lorlatinib
2024
·
E. Bertoli
, E. Da Carlo
, et al.
·
Journal of Thoracic Oncology
PDF
1349P A prospective study on clinicians’ attitudes and survival outcomes for patients with NSCLC and poor performance status in the immunotherapy era: PICASO study (GOIRC-04-2020)
2024
·
F. Facchinetti
, A. Camerini
, et al.
·
Annals of Oncology
EP11.01-01 Final Analysis of First-Line Chemo-Immunotherapy in Patients with Advanced Lung Adenocarcinoma: An Italian Real-World Study
2023
·
A. Leonetti
, F. Perrone
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
35
Citation count:
126
H-index:
5
I10-index:
2
Year
Topic
Type